Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor

Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor

US Patent 9353356 · Granted May 31, 2016

Estimated economic value: $19,296,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using ALK2 inhibitors2025
Methods of treating iron overload with a BMP inhibitor2025
Methods of using activin receptor type IIB variants2025
GDNF fusion polypeptides and methods of use thereof2025
Activin receptor type IIA variants and methods of use thereof2025
ALK7 binding proteins and uses thereof2025
Activin receptor type IIa variants and methods of use thereof2025
Compositions and methods for treating pulmonary hypertension2025
ALK2 antibodies and methods of use thereof2025
Activin receptor type IIB variants and methods of use thereof2025
ALK1 receptor and ligand antagonists and uses thereof2024
ALK1 receptor and ligand antagonists and uses thereof2024